Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary Europe-Reference-Cited by-同舟云学术

Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary Europe

Published:2015-10-05 Issue:3 Volume:117 Page:401-408
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Poyet Cédric¹,Nieboer Daan²,Bhindi Bimal³,Kulkarni Girish S.³,Wiederkehr Caroline¹,Wettstein Marian S.¹,Largo Remo¹,Wild Peter⁴,Sulser Tullio¹,Hermanns Thomas¹

Affiliation:

1. Department of Urology; University Hospital Zürich; University of Zürich; Zürich Switzerland

2. Erasmus MC; University Medical Center Rotterdam; Rotterdam The Netherlands

3. Division of Urology; Department of Surgery; University Health Network; University of Toronto; Toronto ON Canada

4. Institute of Surgical Pathology; University Hospital Zürich; University of Zürich; Zürich Switzerland

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13314/fullpdf

Reference34 articles.

1. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context;Draisma;J Natl Cancer Inst,2009

2. Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC);Schroder;Eur Urol,2012

3. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up;Schroder;Lancet,2014

4. Clinical behavior of prostatic specific antigen and prostatic acid phosphatase: a comparative study;Morote Robles;Eur Urol,1988

5. Overdiagnosis and overtreatment of prostate cancer;Loeb;Eur Urol,2014

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Evaluation of the Kaiser Permanente Prostate Cancer Risk Calculator in Biopsy-Naïve Men With Mild PSA Elevations;Urology Practice;2024-09

2. External Validation of Stockholm3 in a Retrospective German Clinical Cohort;European Urology Focus;2024-08

3. Risk calculators for the detection of prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-06-03

4. Improving Prostate Cancer Risk Prediction through Partial AUC Optimization;Companion Proceedings of the ACM Web Conference 2024;2024-05-13

5. A cost-benefit analysis of mass prostate cancer screening;Cost Effectiveness and Resource Allocation;2024-05-05